Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: A review of morphologic aspects

Urology

Volumn 51, Issue 5 SUPPL. A, 1998, Pages 121-124

  Di Sant'Agnese, P Anthony ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CHROMOGRANIN A; CORTICOTROPIN; LEUCINE ENKEPHALIN; NEURON SPECIFIC ENOLASE; SEROTONIN; VASOPRESSIN;

ARTICLE; CARCINOID; HUMAN; MALE; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SMALL CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; CARCINOID TUMOR; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; HUMANS; MALE; NEUROSECRETORY SYSTEMS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0031834820     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00064-8     Document Type: Article

References (47)

1. di Sant'Agnese P. Neuroendocrine differentiation in carcinoma of the prostate Diagnostic, prognostic, and therapeutic implications . Cancer. 70:1992;254-268.
2. di Sant'Agnese P. Neuroendocrine differentiation in prostatic carcinoma Recent findings and new concepts . Cancer. 75:1995;1850-1859.
3. di Sant'Agnese P., de Mesy Jensen K. Human prostatic endocrine-paracrine (APUD) cells distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains . Arch Pathol Lab Med. 109:1985;607-612.
4. di Sant'Agnese P., de Mesy Jensen K. Endocrine-paracrine cells of the prostate and prostatic urethra; an ultrastructural study. Hum Pathol. 15:1984;1034-1041.
5. Fetissof F., Dubois M.P., Arbeille-Brassart B., et al. Endocrine cells in the prostate gland, urothelium and Brenner tumors immunohistological and ultrastructural studies . Virchows Arch. 42:1983;53-64.
6. Abrahamsson P.-A., Wadstrom L.B., Alumets J., et al. Peptide hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Path Res Pract. 181:1986;675-683.
7. Abrahamsson P.-A., Falkmer S., Falt K., Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas: an immunohistochemical study testing chromogranin A as an "endocrine marker." Pathol Res Pract. 185:1989;373-380.
8. Schmid K., Helpap B., Totsch M., Kirchmair M., Dockhorn-Dworniczak B., Bucker W., et al. Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology. 24:1994;233-239.
9. di Sant'Agnese P.A. Calcitonin-like immunoreactive and bombesin-like immunoreactive endocrine-paracrine cells of the human prostate. Arch Pathol Lab Med. 110:1986;412-415.
10. di Sant'Agnese P., de Mesy Jensen K. Calcitonin, katacalcin and calcitonin gene-related peptide in the human prostate an immunocytochemical and immunoelectron microscopic study . Arch Pathol Lab Med. 113:1989;790-796.
11. Abrahamsson P.-A., Lilja H. Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland. Prostate. 14:1989;71-81.
12. Fetissof F., Arbeille B., Guilloteau D., Lanson Y. Glycoprotein hormone a-chain-immunoreactive endocrine cells in prostate and cloacal derived tissues. Arch Pathol Lab Med. 111:1987;836-840.
13. Sunday M., Kaplan L., Motoyama E., Chin W., Spindel E. Biology of disease Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease . Lab Invest. 59:1988;5-24.
14. di Sant'Agnese P., de Mesy Jensen K. Somatostatin and/or somatostatin-like immunoreactive endocrine-paracrine cells in the human prostate gland. Arch Pathol Lab Med. 108:1984;693-696.
15. Iwamura M., Wu G., Abrahamsson P.-A., di Sant'Agnese P., Cockett A., Deftos L. Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells. Urology. 43:1994;667-674.
16. Iwamura M., Wu G., Abrahamsson P.-A., Cockett A., Foss K., Deftos L. Parathyroid hormone-related protein a potential autocrine growth regulator in human prostate cancer cell lines . Urology. 43:1994;675-679.
17. Bonkhoff H., Stein U., Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Archiv A Pathol Anat Histopathol. 423:1993;291-294.
18. Krijnen J., Janssen P., Ruizveld de Winter J., van Krimpen H., Schroder F., van der Kwast T. Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry. 100:1993;393-398.
19. Wu G., Burzon T., di Sant'Agnese P., Schoen S., Deftos L., Gershagen S., Cockett A. Calcitonin receptor mRNA expression in the human prostate. Urology. 47:1996;376-381.
20. Iwamura M., Benning C., di Sant'Agnese P., Cockett A., Wu G., Gershagen S. Overexpression of human epidermal growth factor receptor and c-erbB-2 by neuroendocrine cells in normal prostatic tissue. Urology. 43:1994;838-843.
21. Pearse A. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic, and pathologic implications of the concepts. J Histochem Cytochem. 17:1969;303-313.
22. Larsson L.-I. On the possible existence of multiple endocrine, paracrine and neurocrine messengers in secretory cell systems. Invest Cell Pathol. 3:1980;73-85.
23. Cutz E. Neuroendocrine cells of the lung an overview of morphologic characteristics and development . Exp Lung Res. 3:1982;185-208.
24. Bishop A., Polak J. Gut endocrine and neural peptides. Endocr Pathol. 1:1990;4-24.
25. Sjoberg H.E., Arver S., Bucht E. High concentration of immunoreactive calcitonin of prostatic origin in human semen. Acta Physiol Scand. 110:1980;101-102.
26. Ulisse S., Gnessi L., Fabbri A., et al. Bombesin-like immunoreactivity in human seminal fluid. Regul Peptides. 19:1987;143.
27. Sasaki A., Yoshinaga K. Immunoreactive somatostatin in male reproductive system in humans. J Clin Endocrinol Metab. 68:1989;996-999.
28. Ro J., Tetu B., Ayala A., et al. Small cell carcinoma of the prostate immunohistochemical and electron microscopic studies of 18 cases . Cancer. 59:1987;977-982.
29. Tetu B., Ro J., Ayala A., et al. Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases . Cancer. 59:1987;1803-1809.
30. Abbas F., Civantos F., Benedetto P., Soloway M. Small cell carcinoma of the bladder and prostate. Urology. 46:1995;617-630.
31. Almagro U., Tieu T., Remeniuk E., et al. Argyrophilic, 'carcinoid-like' prostatic carcinoma. Arch Pathol Lab Med. 110:1986;916-919.
32. Stratton M., Evans D., Lambert I. Prostatic adenocarcinoma evolving into carcinoid selective effect of hormonal treatment? J Clin Pathol. 39:1986;750-756.
33. Abrahamsson P.-A., Wadstrom L., Alumets J., et al. Peptide hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Path Res Pract. 182:1987;298-307.
34. di Sant'Agnese P., de Mesy Jensen K. Neuroendocrine differentiation in prostatic carcinoma. Human Pathology. 18:1987;849-856.
35. Algaba F., Trias I., Lopez L., Rodriguez-Vallejo J., Gonzalez-Esteban J. Neuroendocrine cells in peripheral prostatic zone age, prostatic intraepithelial neoplasia and latent cancer-related changes . Eur Urol. 27:1995;329-333.
36. Weaver M., Abdul-Karim F., Srigley J., Bostwick D., Ro J., Ayala A. Paneth cell-like change of the prostate gland A histological, immunohistochemical, and electron microscopic study . Am J Surg Pathol. 16:1992;62-68.
37. Van de Voorde W., Van Poppel H., Haustermans K., Baert L., Lauweryns J. Mucin-secreting adenocarcinoma of the prostate with neuroendocrine differentiation and Paneth-like cells. Am J Surg Pathol. 18:1994;200-207.
38. Adlakha H., Bostwick D. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation Report of 30 cases . Hum Pathol. 25:1994;135-139.
39. di Sant'Agnese P. Neuroendocrine differentiation in prostatic adenocarcinoma does not represent true Paneth cell differentiation. Human Pathol. 25:1994;115-116.
40. Tarle M., Rados N. Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring comparative study of a multiple tumor marker assay . Prostate. 19:1991;23.
41. Kadmon D., Thompson T., Lynch G., Scardino P. Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol. 146:1991;358-361.
42. Cohen R., Glezerson G., Haffejee Z., Africa D. Prostatic carcinoma histological and immunohistological factors affecting prognosis . Br J Urol. 66:1990;405-410.
43. Berner A., Nesland J., Waehre H., Slide J., Fossa S. Hormone resistant prostatic adenocarcinoma An elevation of prognostic factors in pre- and post-treatment specimens . Br J Cancer. 68:1993;380-384.
44. Weinstein M., Partin A., Veltri R., Epstein J. Neuroendocrine differentiation in prostate cancer enhanced prediction of progression after radical prostatectomy . Hum Pathol. 27:1996;683-687.
45. Grignon D., Caplan R., Sakr W., Porter A., Doggen R., John M., Abrams R., Lawton C. Neuroendocrine (NE) differentiation as a prognostic indicator in locally advanced prostate cancer (PCa). Lab Invest. 72:1995;76A.
46. Aprikian A., Cordon-Cardo C., Fan W., Reuter V. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer. 71:1993;3952-3965.
47. Allen F., VanVelden D., Heyns. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer? Br J Urol. 75:1995;751-754.